UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  July 24, 2015 (July 22, 2015) 

 

VIVEVE MEDICAL, INC.

 (Exact name of registrant as specified in its charter)

 

Yukon Territory, Canada

 

1-11388

 

04-3153858

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

150 Commercial Street

Sunnyvale, California

 

94086

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (408) 530-1900

 

No change

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

 

Item 5.07.  Submission of Matters to a Vote of Security Holders.

 

On July 22, 2015, Viveve Medical, Inc. (the “Company”) held its 2015 Annual and Special Meeting of Stockholders (the “Meeting”).  At the Meeting, the stockholders voted to: (1) elect five directors to the Company’s board of directors (the “Board”); (2) approve an amendment to the Viveve Medical, Inc. 2013 Stock Option and Incentive Plan (also referred to as the PLC Systems, Inc. 2013 Stock Option and Incentive Plan), as amended (the “Plan”), increasing the number of shares of common stock authorized for awards under the Plan from 3,111,587 shares to a total of 10,100,000 shares; (3) ratify the appointment of Burr Pilger Mayer, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015; (4) approve a special resolution authorizing a share consolidation (reverse split) of the common stock of the Company at a ratio of up to 1-for-10, which ratio may be determined by the Board, in its sole discretion, and effective as of a date no more than twelve months from the date of the Meeting; and (5) approve a special resolution authorizing a continuance of the Company into the State of Delaware under the Delaware General Corporation Law (the “DGCL”) and to adopt charter documents of the Company that comply with the DGCL in connection therewith, effective as of such date that is to be determined by the Board, in its sole discretion, no more than twelve months from the date of the Meeting.

 

The proposals were approved based on the voting results as follows:

 

Proposal 1: Election of Five Directors.

 

Director

 

Votes For

 

 

Votes Withheld

 

 

Broker Non-Votes

 

Mark Colella

 

33,340,534

   

10,627

   

1,882,676

 

Daniel Janney

 

33,340,537

   

10,624

   

1,882,676

 

Patricia Scheller

 

33,337,841

   

13,320

   

1,882,676

 

Carl Simpson

 

33,340,526

   

10,635

   

1,882,676

 

Brigitte Smith

 

33,337,853

   

13,308

   

1,882,676

 


Proposal 2: Approve an amendment to the Plan increasing the number of shares of common stock authorized for awards under the Plan from 3,111,587 shares to a total of 10,100,000 shares.

 

Votes For

 

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

32,769,977

 

 

579,236

 

1,948

 

1,882,676

 

 

Proposal 3: Ratify the appointment of Burr Pilger Mayer, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015.

 

Votes For

 

 

Votes Withheld

 

 

 

35,190,803

 

 

43,034

 

 

 

 

Proposal 4: Approve a special resolution authorizing a share consolidation (reverse split) of the common stock of the Company at a ratio of up to 1-for-10, which ratio may be determined by the Board, in its sole discretion, and effective as of a date no more than twelve months from the date of the Meeting.

 

Votes For

 

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

34,247,749

 

 

982,003

 

4,085

 

0

 

 

 

 
 

 

 

Proposal 5: Approve a special resolution authorizing a continuance of the Company into the State of Delaware under the DGCL and to adopt charter documents of the Company that comply with the DGCL in connection therewith, effective as of such date that is to be determined by the Board, in its sole discretion, no more than twelve months from the date of the Meeting.

 

Votes For

 

 

Votes Against

 

Abstentions

 

Broker Non-Votes

 

33,245,558

 

 

104,964

 

639

 

1,882,676

 

 

 

 
 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

  

VIVEVE MEDICAL, INC.

  

 

 

 

  

  

  

  

Date: July 24, 2015

By:

/s/ Patricia Scheller

  

 

 

Name: Patricia Scheller

Title: Chief Executive Officer